APO Research
Talk to an analyst

APO RESEARCH · REPORT

Treatment Planning Systems

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Treatment Planning Systems Market Analysis and Forecast 2026-2032

1 January 2026199 pages

Choose your research edition.

Industry ResearchTreatment Planning Systems Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Treatment Planning Systems Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Treatment Planning Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Treatment Planning Systems Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Treatment Planning Systems Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Treatment Planning Systems market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Treatment Planning Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Treatment Planning Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Treatment Planning Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Treatment Planning Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Treatment Planning Systems include DOSIsoft, Brainlab, Philips, IBA, MIM Software, Accuray Incorporated, RaySearch Laboratories, ViewRay and Elekta, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Treatment Planning Systems, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Treatment Planning Systems, also provides the revenue of main regions and countries. Of the upcoming market potential for Treatment Planning Systems, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Treatment Planning Systems revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Treatment Planning Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Treatment Planning Systems revenue, projected growth trends, production technology, application and end-user industry.

Treatment Planning Systems Segment by Company

DOSIsoft

Brainlab

Philips

IBA

MIM Software

Accuray Incorporated

RaySearch Laboratories

ViewRay

Elekta

Varian

Prowess

Linatech

Treatment Planning Systems Segment by Type

Cloud-based

On-premise

Treatment Planning Systems Segment by Application

Hospitals

Cancer Research Institute

Diagnostic and Treatment Centers

Others

Treatment Planning Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Treatment Planning Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Treatment Planning Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Treatment Planning Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Treatment Planning Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Treatment Planning Systems company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Treatment Planning Systems revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Treatment Planning Systems Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On-premise Major Player Table 4. Global Treatment Planning Systems Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. Cancer Research Institute Major Player Table 7. Diagnostic and Treatment Centers Major Player Table 8. Others Major Player Table 9. Treatment Planning Systems Industry Trends Table 10. Treatment Planning Systems Industry Drivers Table 11. Treatment Planning Systems Industry Opportunities and Challenges Table 12. Treatment Planning Systems Industry Restraints Table 13. Global Treatment Planning Systems Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Treatment Planning Systems Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Treatment Planning Systems Market Share by Region (2021-2026) Table 16. Global Treatment Planning Systems Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Treatment Planning Systems Market Share by Region (2027-2032) Table 18. Global Treatment Planning Systems Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Treatment Planning Systems Revenue Market Share by Players (2021-2026) Table 20. Global Treatment Planning Systems Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Treatment Planning Systems Key Players Headquarters & Area Served Table 22. Global Treatment Planning Systems Players, Product Type & Application Table 23. Global Treatment Planning Systems Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Treatment Planning Systems by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Treatment Planning Systems Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Treatment Planning Systems Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Treatment Planning Systems Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Treatment Planning Systems Revenue Market Share by Type (2021-2026) Table 30. Global Treatment Planning Systems Revenue Market Share by Type (2027-2032) Table 31. Global Treatment Planning Systems Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Treatment Planning Systems Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Treatment Planning Systems Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Treatment Planning Systems Revenue Market Share by Application (2021-2026) Table 35. Global Treatment Planning Systems Revenue Market Share by Application (2027-2032) Table 36. DOSIsoft Company Information Table 37. DOSIsoft Business Overview Table 38. DOSIsoft Treatment Planning Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. DOSIsoft Treatment Planning Systems Product Portfolio Table 40. DOSIsoft Recent Development Table 41. Brainlab Company Information Table 42. Brainlab Business Overview Table 43. Brainlab Treatment Planning Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Brainlab Treatment Planning Systems Product Portfolio Table 45. Brainlab Recent Development Table 46. Philips Company Information Table 47. Philips Business Overview Table 48. Philips Treatment Planning Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Philips Treatment Planning Systems Product Portfolio Table 50. Philips Recent Development Table 51. IBA Company Information Table 52. IBA Business Overview Table 53. IBA Treatment Planning Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. IBA Treatment Planning Systems Product Portfolio Table 55. IBA Recent Development Table 56. MIM Software Company Information Table 57. MIM Software Business Overview Table 58. MIM Software Treatment Planning Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. MIM Software Treatment Planning Systems Product Portfolio Table 60. MIM Software Recent Development Table 61. Accuray Incorporated Company Information Table 62. Accuray Incorporated Business Overview Table 63. Accuray Incorporated Treatment Planning Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Accuray Incorporated Treatment Planning Systems Product Portfolio Table 65. Accuray Incorporated Recent Development Table 66. RaySearch Laboratories Company Information Table 67. RaySearch Laboratories Business Overview Table 68. RaySearch Laboratories Treatment Planning Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. RaySearch Laboratories Treatment Planning Systems Product Portfolio Table 70. RaySearch Laboratories Recent Development Table 71. ViewRay Company Information Table 72. ViewRay Business Overview Table 73. ViewRay Treatment Planning Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. ViewRay Treatment Planning Systems Product Portfolio Table 75. ViewRay Recent Development Table 76. Elekta Company Information Table 77. Elekta Business Overview Table 78. Elekta Treatment Planning Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Elekta Treatment Planning Systems Product Portfolio Table 80. Elekta Recent Development Table 81. Varian Company Information Table 82. Varian Business Overview Table 83. Varian Treatment Planning Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Varian Treatment Planning Systems Product Portfolio Table 85. Varian Recent Development Table 86. Prowess Company Information Table 87. Prowess Business Overview Table 88. Prowess Treatment Planning Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Prowess Treatment Planning Systems Product Portfolio Table 90. Prowess Recent Development Table 91. Linatech Company Information Table 92. Linatech Business Overview Table 93. Linatech Treatment Planning Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Linatech Treatment Planning Systems Product Portfolio Table 95. Linatech Recent Development Table 96. North America Treatment Planning Systems Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Treatment Planning Systems Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Treatment Planning Systems Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Treatment Planning Systems Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Treatment Planning Systems Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Treatment Planning Systems Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Treatment Planning Systems Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Treatment Planning Systems Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Treatment Planning Systems Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Treatment Planning Systems Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Treatment Planning Systems Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Treatment Planning Systems Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Treatment Planning Systems Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Treatment Planning Systems Revenue by Country (US$ Million) & (2027-2032) Table 110. China Treatment Planning Systems Revenue by Type (2021-2026) & (US$ Million) Table 111. China Treatment Planning Systems Revenue by Type (2027-2032) & (US$ Million) Table 112. China Treatment Planning Systems Revenue by Application (2021-2026) & (US$ Million) Table 113. China Treatment Planning Systems Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Treatment Planning Systems Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Treatment Planning Systems Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Treatment Planning Systems Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Treatment Planning Systems Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Treatment Planning Systems Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Treatment Planning Systems Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Treatment Planning Systems Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Treatment Planning Systems Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Treatment Planning Systems Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Treatment Planning Systems Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Treatment Planning Systems Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Treatment Planning Systems Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Treatment Planning Systems Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Treatment Planning Systems Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Treatment Planning Systems Image Figure 2. Global Treatment Planning Systems Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Treatment Planning Systems Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-premise Image Figure 6. Global Treatment Planning Systems Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Treatment Planning Systems Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Cancer Research Institute Image Figure 10. Diagnostic and Treatment Centers Image Figure 11. Others Image Figure 12. Global Treatment Planning Systems Market Size (US$ Million) & (2021-2032) Figure 13. Global Treatment Planning Systems Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Treatment Planning Systems Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Treatment Planning Systems Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Treatment Planning Systems Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Treatment Planning Systems Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Treatment Planning Systems Revenue Market Share by Type (2021-2032) Figure 20. Global Treatment Planning Systems Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Treatment Planning Systems Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Treatment Planning Systems Revenue Market Share by Application (2021-2032) Figure 23. North America Treatment Planning Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Treatment Planning Systems Revenue Share by Type (2021-2032) Figure 25. North America Treatment Planning Systems Revenue Share by Application (2021-2032) Figure 26. North America Treatment Planning Systems Revenue Share by Country (2021-2032) Figure 27. United States Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Treatment Planning Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Treatment Planning Systems Revenue Share by Type (2021-2032) Figure 32. Europe Treatment Planning Systems Revenue Share by Application (2021-2032) Figure 33. Europe Treatment Planning Systems Revenue Share by Country (2021-2032) Figure 34. Germany Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Treatment Planning Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Treatment Planning Systems Revenue Share by Type (2021-2032) Figure 44. China Treatment Planning Systems Revenue Share by Application (2021-2032) Figure 45. Asia Treatment Planning Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Treatment Planning Systems Revenue Share by Type (2021-2032) Figure 47. Asia Treatment Planning Systems Revenue Share by Application (2021-2032) Figure 48. Asia Treatment Planning Systems Revenue Share by Region (2021-2032) Figure 49. Japan Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Treatment Planning Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Treatment Planning Systems Revenue Share by Type (2021-2032) Figure 57. SAMEA Treatment Planning Systems Revenue Share by Application (2021-2032) Figure 58. SAMEA Treatment Planning Systems Revenue Share by Country (2021-2032) Figure 59. Brazil Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Treatment Planning Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Hospitals
  • Cancer Research Institute
  • Diagnostic and Treatment Centers
  • Others
Companies covered
  • DOSIsoft
  • Brainlab
  • Philips
  • IBA
  • MIM Software
  • Accuray Incorporated
  • RaySearch Laboratories
  • ViewRay
  • Elekta
  • Varian
  • Prowess
  • Linatech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Treatment Planning Systems Market by Type
  3. 1.2.1 Global Treatment Planning Systems Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-premise
  6. 1.3 Treatment Planning Systems Market by Application
  7. 1.3.1 Global Treatment Planning Systems Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Cancer Research Institute
  10. 1.3.4 Diagnostic and Treatment Centers
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Treatment Planning Systems Market Dynamics
  1. 2.1 Treatment Planning Systems Industry Trends
  2. 2.2 Treatment Planning Systems Industry Drivers
  3. 2.3 Treatment Planning Systems Industry Opportunities and Challenges
  4. 2.4 Treatment Planning Systems Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Treatment Planning Systems Market Perspective (2021-2032)
  2. 3.2 Global Treatment Planning Systems Growth Trends by Region
  3. 3.2.1 Global Treatment Planning Systems Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Treatment Planning Systems Market Size by Region (2021-2026)
  5. 3.2.3 Global Treatment Planning Systems Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Treatment Planning Systems Revenue by Players
  2. 4.1.1 Global Treatment Planning Systems Revenue by Players (2021-2026)
  3. 4.1.2 Global Treatment Planning Systems Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Treatment Planning Systems Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Treatment Planning Systems Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Treatment Planning Systems Key Players Headquarters & Area Served
  7. 4.4 Global Treatment Planning Systems Players, Product Type & Application
  8. 4.5 Global Treatment Planning Systems Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Treatment Planning Systems Market CR5 and HHI
  11. 4.6.3 2025 Treatment Planning Systems Tier 1, Tier 2, and Tier 3
5 Treatment Planning Systems Market Size by Type
  1. 5.1 Global Treatment Planning Systems Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Treatment Planning Systems Revenue by Type (2021-2032)
  3. 5.3 Global Treatment Planning Systems Revenue Market Share by Type (2021-2032)
6 Treatment Planning Systems Market Size by Application
  1. 6.1 Global Treatment Planning Systems Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Treatment Planning Systems Revenue by Application (2021-2032)
  3. 6.3 Global Treatment Planning Systems Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 DOSIsoft
  2. 7.1.1 DOSIsoft Company Information
  3. 7.1.2 DOSIsoft Business Overview
  4. 7.1.3 DOSIsoft Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  5. 7.1.4 DOSIsoft Treatment Planning Systems Product Portfolio
  6. 7.1.5 DOSIsoft Recent Developments
  7. 7.2 Brainlab
  8. 7.2.1 Brainlab Company Information
  9. 7.2.2 Brainlab Business Overview
  10. 7.2.3 Brainlab Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Brainlab Treatment Planning Systems Product Portfolio
  12. 7.2.5 Brainlab Recent Developments
  13. 7.3 Philips
  14. 7.3.1 Philips Company Information
  15. 7.3.2 Philips Business Overview
  16. 7.3.3 Philips Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Philips Treatment Planning Systems Product Portfolio
  18. 7.3.5 Philips Recent Developments
  19. 7.4 IBA
  20. 7.4.1 IBA Company Information
  21. 7.4.2 IBA Business Overview
  22. 7.4.3 IBA Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  23. 7.4.4 IBA Treatment Planning Systems Product Portfolio
  24. 7.4.5 IBA Recent Developments
  25. 7.5 MIM Software
  26. 7.5.1 MIM Software Company Information
  27. 7.5.2 MIM Software Business Overview
  28. 7.5.3 MIM Software Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  29. 7.5.4 MIM Software Treatment Planning Systems Product Portfolio
  30. 7.5.5 MIM Software Recent Developments
  31. 7.6 Accuray Incorporated
  32. 7.6.1 Accuray Incorporated Company Information
  33. 7.6.2 Accuray Incorporated Business Overview
  34. 7.6.3 Accuray Incorporated Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Accuray Incorporated Treatment Planning Systems Product Portfolio
  36. 7.6.5 Accuray Incorporated Recent Developments
  37. 7.7 RaySearch Laboratories
  38. 7.7.1 RaySearch Laboratories Company Information
  39. 7.7.2 RaySearch Laboratories Business Overview
  40. 7.7.3 RaySearch Laboratories Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  41. 7.7.4 RaySearch Laboratories Treatment Planning Systems Product Portfolio
  42. 7.7.5 RaySearch Laboratories Recent Developments
  43. 7.8 ViewRay
  44. 7.8.1 ViewRay Company Information
  45. 7.8.2 ViewRay Business Overview
  46. 7.8.3 ViewRay Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  47. 7.8.4 ViewRay Treatment Planning Systems Product Portfolio
  48. 7.8.5 ViewRay Recent Developments
  49. 7.9 Elekta
  50. 7.9.1 Elekta Company Information
  51. 7.9.2 Elekta Business Overview
  52. 7.9.3 Elekta Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Elekta Treatment Planning Systems Product Portfolio
  54. 7.9.5 Elekta Recent Developments
  55. 7.10 Varian
  56. 7.10.1 Varian Company Information
  57. 7.10.2 Varian Business Overview
  58. 7.10.3 Varian Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Varian Treatment Planning Systems Product Portfolio
  60. 7.10.5 Varian Recent Developments
  61. 7.11 Prowess
  62. 7.11.1 Prowess Company Information
  63. 7.11.2 Prowess Business Overview
  64. 7.11.3 Prowess Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Prowess Treatment Planning Systems Product Portfolio
  66. 7.11.5 Prowess Recent Developments
  67. 7.12 Linatech
  68. 7.12.1 Linatech Company Information
  69. 7.12.2 Linatech Business Overview
  70. 7.12.3 Linatech Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Linatech Treatment Planning Systems Product Portfolio
  72. 7.12.5 Linatech Recent Developments
8 North America
  1. 8.1 North America Treatment Planning Systems Revenue (2021-2032)
  2. 8.2 North America Treatment Planning Systems Revenue by Type (2021-2032)
  3. 8.2.1 North America Treatment Planning Systems Revenue by Type (2021-2026)
  4. 8.2.2 North America Treatment Planning Systems Revenue by Type (2027-2032)
  5. 8.3 North America Treatment Planning Systems Revenue Share by Type (2021-2032)
  6. 8.4 North America Treatment Planning Systems Revenue by Application (2021-2032)
  7. 8.4.1 North America Treatment Planning Systems Revenue by Application (2021-2026)
  8. 8.4.2 North America Treatment Planning Systems Revenue by Application (2027-2032)
  9. 8.5 North America Treatment Planning Systems Revenue Share by Application (2021-2032)
  10. 8.6 North America Treatment Planning Systems Revenue by Country
  11. 8.6.1 North America Treatment Planning Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Treatment Planning Systems Revenue by Country (2021-2026)
  13. 8.6.3 North America Treatment Planning Systems Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Treatment Planning Systems Revenue (2021-2032)
  2. 9.2 Europe Treatment Planning Systems Revenue by Type (2021-2032)
  3. 9.2.1 Europe Treatment Planning Systems Revenue by Type (2021-2026)
  4. 9.2.2 Europe Treatment Planning Systems Revenue by Type (2027-2032)
  5. 9.3 Europe Treatment Planning Systems Revenue Share by Type (2021-2032)
  6. 9.4 Europe Treatment Planning Systems Revenue by Application (2021-2032)
  7. 9.4.1 Europe Treatment Planning Systems Revenue by Application (2021-2026)
  8. 9.4.2 Europe Treatment Planning Systems Revenue by Application (2027-2032)
  9. 9.5 Europe Treatment Planning Systems Revenue Share by Application (2021-2032)
  10. 9.6 Europe Treatment Planning Systems Revenue by Country
  11. 9.6.1 Europe Treatment Planning Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Treatment Planning Systems Revenue by Country (2021-2026)
  13. 9.6.3 Europe Treatment Planning Systems Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Treatment Planning Systems Revenue (2021-2032)
  2. 10.2 China Treatment Planning Systems Revenue by Type (2021-2032)
  3. 10.2.1 China Treatment Planning Systems Revenue by Type (2021-2026)
  4. 10.2.2 China Treatment Planning Systems Revenue by Type (2027-2032)
  5. 10.3 China Treatment Planning Systems Revenue Share by Type (2021-2032)
  6. 10.4 China Treatment Planning Systems Revenue by Application (2021-2032)
  7. 10.4.1 China Treatment Planning Systems Revenue by Application (2021-2026)
  8. 10.4.2 China Treatment Planning Systems Revenue by Application (2027-2032)
  9. 10.5 China Treatment Planning Systems Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Treatment Planning Systems Revenue (2021-2032)
  2. 11.2 Asia Treatment Planning Systems Revenue by Type (2021-2032)
  3. 11.2.1 Asia Treatment Planning Systems Revenue by Type (2021-2026)
  4. 11.2.2 Asia Treatment Planning Systems Revenue by Type (2027-2032)
  5. 11.3 Asia Treatment Planning Systems Revenue Share by Type (2021-2032)
  6. 11.4 Asia Treatment Planning Systems Revenue by Application (2021-2032)
  7. 11.4.1 Asia Treatment Planning Systems Revenue by Application (2021-2026)
  8. 11.4.2 Asia Treatment Planning Systems Revenue by Application (2027-2032)
  9. 11.5 Asia Treatment Planning Systems Revenue Share by Application (2021-2032)
  10. 11.6 Asia Treatment Planning Systems Revenue by Country
  11. 11.6.1 Asia Treatment Planning Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Treatment Planning Systems Revenue by Country (2021-2026)
  13. 11.6.3 Asia Treatment Planning Systems Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Treatment Planning Systems Revenue (2021-2032)
  2. 12.2 SAMEA Treatment Planning Systems Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Treatment Planning Systems Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Treatment Planning Systems Revenue by Type (2027-2032)
  5. 12.3 SAMEA Treatment Planning Systems Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Treatment Planning Systems Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Treatment Planning Systems Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Treatment Planning Systems Revenue by Application (2027-2032)
  9. 12.5 SAMEA Treatment Planning Systems Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Treatment Planning Systems Revenue by Country
  11. 12.6.1 SAMEA Treatment Planning Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Treatment Planning Systems Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Treatment Planning Systems Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst